LD 1162 LR 786(02)
An Act To Further Expand Drug Price Transparency
Fiscal Note for Bill as Amended by Committee Amendment " "
Committee: Health Coverage, Insurance and Financial Services
Fiscal Note Required: Yes
Fiscal Note
Minor cost increase - General Fund
Minor revenue increase - General Fund
Minor revenue increase - Other Special Revenue Funds
Correctional and Judicial Impact Statements
The additional workload associated with the minimal number of new cases filed in the court system does not require additional funding at this time.
The collection of additional fine revenue will increase General Fund and dedicated revenue by minor amounts.
Fiscal Detail and Notes
The bill requires prescription drug manufacturers to report to the Maine Health Data Organization (MHDO) on prescription drug information under certain situations or when requested by MHDO and requires MHDO to annually produce and post a report of this information on its website. Any costs to MHDO to carry out these provisions are expected to be minor and can be absorbed within budgeted resources. The bill also authorizes MHDO to collect an annual assessment on drug manufacturers of $500. Additional revenues collected from these assessments are expected to increase Other Special Revenue Fund revenues by minor amounts.